POSTER 24

Long-Term Safety and Efficacy of Tralokinumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Treated for Up to 6 Years

Andrew Blauvelt, Vivian Laquer, Richard G Langley, H. Chih-ho Hong, Christian Bjerregård Øland, Le Gjerum, Ann-Marie Tindberg, Kristian Reich

< Previous Poster | Next Poster >

Poster 24